文献速递产科母胎医学

子痫前期计划分娩或期待治疗:个体参与者数据Meta分析

Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2022-04-26

该个体参与者数据Meta分析纳入6项试验共1790名34周起子痫前期孕妇,比较计划分娩与期待治疗。计划分娩显著降低母体发病率(2.6% vs 4.4%;校正RR 0.59;95%CI 0.36-0.98),但增加围产期主要复合结局(20.9% vs 17.1%;校正RR 1.22;95%CI 1.01-1.47),主要由短期新生儿呼吸系统疾病驱动;期待治疗组小于胎龄儿更多(7.8% vs 10.6%;RR 0.74;95%CI 0.55-0.99)。

要点

  • 34周起子痫前期计划分娩较期待治疗降低母体发病率(校正RR 0.59;95%CI 0.36-0.98)。
  • 计划分娩增加围产期主要复合结局(校正RR 1.22;95%CI 1.01-1.47),由短期新生儿呼吸系统疾病驱动。
  • 期待治疗组小于胎龄儿更多(7.8% vs 10.6%;RR 0.74;95%CI 0.55-0.99)。

核心结论

  • 晚期早产子痫前期计划早期分娩提供明确的母体获益,并可能降低小于胎龄儿风险,但短期新生儿呼吸系统疾病可能增加。
  • 应与孕妇讨论延长子痫前期妊娠的潜在获益与风险,作为共同决策的一部分。

研究设计与样本

  • 个体参与者数据Meta分析,检索2000年1月1日至2021年12月18日发表的试验,纳入6项试验共1790名34周起子痫前期孕妇。
  • 纳入单胎或多胎妊娠,主要母体结局为母体死亡或发病复合结局,主要围产期结局为围产期死亡或发病复合结局。
  • 按意向性治疗原则分析所有预设结局的可用数据,主要个体患者数据分析采用1阶段固定效应模型。

主要发现

  • 计划分娩组母体发病率2.6% vs 期待治疗组4.4%(校正RR 0.59;95%CI 0.36-0.98)。
  • 计划分娩组围产期主要复合结局20.9% vs 期待治疗组17.1%(校正RR 1.22;95%CI 1.01-1.47),由短期新生儿呼吸系统疾病驱动。
  • 期待治疗组小于胎龄儿7.8% vs 计划分娩组10.6%(RR 0.74;95%CI 0.55-0.99)。

临床怎么用

  • 作者认为,应与孕妇讨论延长子痫前期妊娠的潜在获益与风险,作为共同决策的一部分。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pregnancy hypertension is a leading cause of maternal and perinatal mortality and morbidity. Between 34+0 and 36+6 weeks gestation, it is uncertain whether planned delivery could reduce maternal complications without serious neonatal consequences. In this individual participant data meta-analysis, we aimed to compare planned delivery to expectant management, focusing specifically on women with preeclampsia. DATA SOURCES: We performed an electronic database search using a prespecified search strategy, including trials published between January 1, 2000 and December 18, 2021. We sought individual participant-level data from all eligible trials. STUDY ELIGIBILITY CRITERIA: We included women with singleton or multifetal pregnancies with preeclampsia from 34 weeks gestation onward. METHODS: The primary maternal outcome was a composite of maternal mortality or morbidity. The primary perinatal outcome was a composite of perinatal mortality or morbidity. We analyzed all the available data for each prespecified outcome on an intention-to-treat basis. For primary individual patient data analyses, we used a 1-stage fixed effects model. RESULTS: We included 1790 participants from 6 trials in our analysis. Planned delivery from 34 weeks gestation onward significantly reduced the risk of maternal morbidity (2.6% vs 4.4%; adjusted risk ratio, 0.59; 95% confidence interval, 0.36-0.98) compared with expectant management. The primary composite perinatal outcome was increased by planned delivery (20.9% vs 17.1%; adjusted risk ratio, 1.22; 95% confidence interval, 1.01-1.47), driven by short-term neonatal respiratory morbidity. However, infants in the expectant management group were more likely to be born small for gestational age (7.8% vs 10.6%; risk ratio, 0.74; 95% confidence interval, 0.55-0.99). CONCLUSION: Planned early delivery in women with late preterm preeclampsia provides clear maternal benefits and may reduce the risk of the infant being born small for gestational age, with a possible increase in short-term neonatal respiratory morbidity. The potential benefits and risks of prolonging a pregnancy complicated by preeclampsia should be discussed with women as part of a shared decision-making process.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Beardmore-Gray A, Seed PT, Fleminger J, et al. Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol. 2022. PMID: 35487323. doi:10.1016/j.ajog.2022.04.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。